Ivan Bieche Selected Research

Ivan Bieche Research Topics

Disease

75	Neoplasms (Cancer) 10/2023 - 07/2004
36	Breast Neoplasms (Breast Cancer) 01/2024 - 09/2002
11	Carcinogenesis 10/2020 - 04/2003
10	Urinary Bladder Neoplasms (Bladder Cancer) 10/2020 - 04/2003
8	Carcinoma (Carcinomatosis) 01/2020 - 04/2003
7	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2007
5	Triple Negative Breast Neoplasms 10/2023 - 01/2014
5	Adenocarcinoma 11/2021 - 10/2008
5	Squamous Cell Carcinoma of Head and Neck 01/2020 - 07/2008
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 09/2011
4	Non-Muscle Invasive Bladder Neoplasms 10/2019 - 06/2013
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2022 - 10/2017
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2011
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 12/2017
3	Inflammation (Inflammations) 01/2018 - 02/2008
3	Melanoma (Melanoma, Malignant) 01/2017 - 09/2007
3	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 06/2015 - 01/2010
2	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 09/2023
2	Lung Neoplasms (Lung Cancer) 02/2023 - 01/2023
2	Disease Progression 02/2023 - 08/2012
2	Microsatellite Instability 02/2023 - 12/2022
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 06/2015
2	Alcoholic Fatty Liver 01/2021 - 05/2011
2	Liver Diseases (Liver Disease) 01/2021 - 07/2019
2	Retinal Degeneration 10/2020 - 01/2017
2	Stomach Neoplasms (Stomach Cancer) 07/2019 - 03/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2016 - 03/2014
2	Head and Neck Neoplasms (Head and Neck Cancer) 06/2015 - 07/2008
2	Glioblastoma (Glioblastoma Multiforme) 03/2014 - 02/2013
2	Inflammatory Breast Neoplasms 10/2013 - 02/2008
2	Meningioma (Meningiomas) 07/2010 - 07/2009

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 01/2024 - 04/2011
20	Messenger RNA (mRNA)IBA 01/2022 - 09/2002
20	Proteins (Proteins, Gene)FDA Link 04/2021 - 09/2002
10	Estrogen ReceptorsIBA 01/2018 - 07/2004
9	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 04/2011
6	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2014 - 10/2004
6	Tamoxifen FDA LinkGeneric 02/2012 - 01/2008
6	Estrogen Receptor alphaIBA 02/2009 - 07/2004
5	Phenobarbital (Luminal)FDA Link 01/2023 - 01/2014
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 07/2009
4	ParaffinIBA 01/2020 - 01/2017
4	Formaldehyde (Formol)FDA Link 01/2020 - 01/2017
4	Protein Isoforms (Isoforms)IBA 07/2019 - 07/2004
4	Circulating Tumor DNAIBA 03/2019 - 04/2015
4	EnzymesIBA 01/2019 - 04/2003
4	MicroRNAs (MicroRNA)IBA 07/2015 - 06/2013
3	Bevacizumab (Avastin)FDA Link 11/2023 - 03/2014
3	NivolumabIBA 01/2023 - 11/2019
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 07/2019
3	RNA (Ribonucleic Acid)IBA 09/2020 - 07/2016
3	CytokinesIBA 01/2020 - 09/2005
3	ChemokinesIBA 01/2020 - 09/2005
3	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2018
3	LigandsIBA 01/2018 - 07/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015 - 01/2008
3	Cerebroside-Sulfatase (Arylsulfatase A)IBA 06/2015 - 01/2010
3	Estrogens (Estrogen)FDA Link 03/2008 - 07/2004
2	Hormones (Hormone)IBA 01/2024 - 07/2015
2	exemestane (Aromasin)FDA Link 01/2024 - 07/2007
2	TOR Serine-Threonine KinasesIBA 01/2024 - 10/2008
2	Everolimus FDA Link 01/2024 - 06/2016
2	Cell-Free Nucleic AcidsIBA 12/2022 - 03/2019
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022 - 01/2018
2	Tryptophan (L-Tryptophan)FDA Link 01/2022 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
2	durvalumabIBA 01/2022 - 01/2021
2	pembrolizumabIBA 11/2021 - 11/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 01/2015
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 12/2013
2	B7-H1 AntigenIBA 01/2021 - 01/2017
2	InterferonsIBA 10/2020 - 10/2010
2	TubulinIBA 10/2020 - 01/2017
2	Cetuximab (Erbitux)FDA Link 01/2020 - 06/2015
2	PlatinumIBA 11/2019 - 09/2011
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 08/2019 - 01/2016
2	Trastuzumab (Herceptin)FDA Link 11/2018 - 11/2005
2	human ERBB2 proteinIBA 01/2018 - 01/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 04/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 10/2015
2	Carboplatin (JM8)FDA LinkGeneric 09/2016 - 07/2008
2	Sunitinib (Sutent)FDA Link 06/2016 - 05/2011
2	Sorafenib (BAY 43-9006)FDA Link 06/2016 - 05/2011
2	Cisplatin (Platino)FDA LinkGeneric 06/2015 - 09/2011
2	Antineoplastic Agents (Antineoplastics)IBA 09/2014 - 09/2011
2	Transcription Factors (Transcription Factor)IBA 02/2013 - 07/2010
2	Sulfoglycosphingolipids (Sulfatides)IBA 08/2012 - 01/2010
2	Fluorouracil (Carac)FDA LinkGeneric 09/2011 - 03/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2011 - 07/2008
2	VimentinIBA 05/2011 - 05/2010
2	Cadherins (E-Cadherin)IBA 05/2011 - 05/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 04/2011 - 03/2010
2	Protein Kinase CIBA 05/2010 - 05/2009

Therapy/Procedure

29	Therapeutics 01/2024 - 12/2005
11	Drug Therapy (Chemotherapy) 10/2023 - 03/2008
8	Immunotherapy 10/2023 - 01/2017
4	Precision Medicine 01/2022 - 04/2011
3	Chemoradiotherapy 01/2023 - 06/2015
3	Radiotherapy 01/2021 - 09/2016
2	Cystectomy 10/2019 - 01/2017